Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biomark Diagnostics Inc. (OTC: BMKDF).

Full DD Report for BMKDF

You must become a subscriber to view this report.


Recent News from (OTC: BMKDF)

Dr. Myron Weisfedlt Joins BioMark's Scientific Advisory Team
(via TheNewswire) Vancouver, British Columbia / TheNewswire / November 5 th , 2018 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX, FSE: 20B, OTCQB: BMKDF) is pleased to announce that Dr. Myron Weisfeldt will be joining BioMark's Scientific Advisory Team. Mr. Rashid Ahm...
Source: TheNewsWire
Date: November, 05 2018 08:00
BioMark Closes Final Tranche of Private Placement Offering
(via TheNewswire) October 4 th , 2018 / TheNewswire / Vancouver, British Columbia - BioMark Diagnostics Inc. ("BioMark" or the "Company") (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that further to its press release of September 20, 2017, it has closed the ...
Source: TheNewsWire
Date: October, 04 2018 09:00
Dr. Sandeep Singhal Joins BioMark Scientific Advisory Team
(via TheNewswire) October 2 , 2018 / TheNewswire / Vancouver, British Columbia - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that it has appointed Dr. Sandeep Singhal to its scientific advisory team. ...
Source: TheNewsWire
Date: October, 02 2018 09:00
BioMark Contributes in Scientific Publication
(via TheNewswire) Vancouver, British Columbia / TheNewswire / September 2 6 , 2018 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that the article spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker i...
Source: TheNewsWire
Date: September, 26 2018 09:00
Dr. Paramjit Tappia Joins BioMark Scientific Advisory Team
(via TheNewswire) Vancouver, British Columbia / TheNewswire / September 19 th , 2018 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that it has appointed Dr. Paramjit Tappia to its scientific advisory team. ...
Source: TheNewsWire
Date: September, 19 2018 09:00
BioMark Partners with Alberta Machine Intelligence Institute to Amplify Clinical Diagnostic Decision Making
(via TheNewswire) Vancouver, British Columbia / TheNewswire / April 25, 2018 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX, FSE: 20B, OTCMKTS: BMKDF) is pleased to announce that it has penned a deal with the Alberta Machine Intelligence Institute (Amii) led by Dr. Os...
Source: TheNewsWire
Date: April, 25 2018 09:00
BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant
(via TheNewswire) Vancouver, British Columbia / TheNewswire / (February 27th, 2018)- BioMark Diagnostics Inc. (CSE: BUX, FSE: 20B, OTCMKTS: BMKDF) announces the award of a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to partner with Don...
Source: TheNewsWire
Date: February, 27 2018 09:00
BIOMARK's Health Canada Submission Update
(via TheNewswire) Vancouver, British Columbia / TheNewswire / February 21, 2018 - BioMark Diagnostics Inc . ("BioMark") (CSE: BUX, FSE: 20B , OTC MKTS: BMKDF ) is pleased to provide an update on its Health Canada submission progress following data analysis on its clinical tria...
Source: TheNewsWire
Date: February, 21 2018 09:00
Further Progress in BIOMARK's Clinical Trial and Regulatory Review
(via TheNewswire) Vancouver, British Columbia / TheNewswire / January 3 rd , 2018 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX, FSE: 20B , OTC MKTS: BMKDF ) is pleased to provide further progress on its clinical trial activities as previously reported on November 1 s...
Source: TheNewsWire
Date: January, 03 2018 09:00
Global Affairs Canada Supports BioMark's Trip to Japan
(via TheNewswire) Vancouver, British Columbia / TheNewswire / December 19, 2017 - BioMark Diagnostics Inc. ("BioMark") (CSE: BUX, FSE: 20B , OTC MKTS: BMKDF ) is proud to announce that the Canadian Government's established Going Global International (GGI) program has generously appr...
Source: TheNewsWire
Date: December, 19 2017 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-11N/A0.04226N/AN/A0
2018-12-10N/A0.04226N/AN/A0
2018-12-07N/A0.04226N/AN/A0
2018-12-06N/A0.04226N/AN/A0
2018-12-05N/A0.04226N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-09-17400400100.0000Short
2018-04-26500500100.0000Short
2018-01-291,0001,90052.6316Short
2018-01-269,00010,00090.0000Short
2018-01-02750750100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BMKDF.


About Biomark Diagnostics Inc. (OTC: BMKDF)

Logo for Biomark Diagnostics Inc. (OTC: BMKDF)

BioMark is developing proprietary, non invasive, and accurate cancer diagnostic solutions which can help detect cancer early and cost effectively. The technology can also be used for measuring response to treatment and potentially for serial monitoring for cancer survivors.

 

 

 

Current Management

  • Rashid Ahmed / CEO, President
  • Abbey Abdiye / CFO
  • Brian Kia Ming Cheng /
  • Bramhananad Ramjiawan /

Current Share Structure

  • Market Cap: $3,647,248 - 03/09/2018
  • Authorized: 54,436,543 - 01/16/2015
  • Issue and Outstanding: 54,436,543 - 02/08/2017

 



Daily Technical Chart for (OTC: BMKDF)

Daily Technical Chart for (OTC: BMKDF)


Stay tuned for daily updates and more on (OTC: BMKDF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BMKDF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BMKDF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BMKDF and does not buy, sell, or trade any shares of BMKDF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/